Hydrocephalus Treatment: Surgical Innovations and Clinical Management
Hydrocephalus, which in neurological sciences means water accumulation in the brain but the pathophysiology involved is very multifactorial, is an abnormal accumulation in the ventricular system arising from an imbalance in the production and absorption of cerebrospinal fluid (CSF). This builds up intracranial pressure (ICP) which causes pressure on the parenchymal tissue and if the pressure is not controlled can cause serious problems such as head enlargement in infants or cognitive deficit and irreversible loss of vital function in adults.
Nowadays, advanced shunt systems and adjustable valve technologies from internationally located medical technology manufacturers, including Desu, dominate how surgeons handle this condition. The success of hydrocephalus therapy is not only an example of fluid drainage but depends on a surgical strategy suitable for the patient´s age, pathology (congenital or acquired) and fluid dynamics. In this review, it explores medical technology and Desu technologies in this regard.
Surgical Options for Acute vs. Chronic Hydrocephalus
Hydrocephalus management includes two different strategic approaches according to the onset date of the disease. Surgical Options for Acute vs. Chronic Hydrocephalus determines the urgency for intervention and the instrument.
Acute Hydrocephalus Management: This is usually due to traumatic brain injury, aneurysmal bleeding, or tumor compression causing the ventricles to expand at an excessive rate. This means that brain tissue does not adapt (compliance) to this rapid transition. In this case, the aim is for life-saving decompression rather than permanent shunting.
Chronic Hydrocephalus management: Congenital (or birth) anomalies or Normal Pressure Hydrocephalus (NPH) present in elderly individuals are treated much slower. Here the aim is to enhance the patient’s quality of life while establishing an efficient drainage pathway in the long run. Right now, the Desu Ventriculo-Peritoneal (VP) Shunt systems enter play. Biocompatible permanent implants used in chronic process are vitally important. And they must also be adaptive (changing) according to the individual’s new needs.
The Role of EVD in Acute Hydrocephalus Management
Since the fluid in the ventricle may be bloody or high in protein, which can block the permanent shunt, in acute crises it may be contraindicated to place a permanent shunt. Here is the role of an EVD with Acute Hydrocephalus Management:
External Ventricular Drainage. EVD systems provide a temporary solution for intraventricular hemorrhage (IVH) or acute infection (meningitis). Two primary advantages of Desu’s EVD solutions for surgeons are:
Controlled Drainage: Removes high pressure and contaminated (bloody/infected) fluid from the body to relieve and cleanse the brain.
Monitoring: By reading intracranial pressure (ICP) instantly through the same line, it helps to decide when a patient is ready for a permanent shunt. For instance, after clearance of the acute phase, cleaning of CSF and restoration of protein level (back to normal), removal of the EVD and transition to shunt surgery (the permanent therapy).
Endoscopic Third Ventriculostomy (ETV) vs. Shunting
When it comes to the Endoscopic Third Ventriculostomy (ETV) vs. Shunting, to date shunt therapy has become the gold standard for permanent treatment, with endoscopic modalities emerging due to advancements in technology. The first step in Endoscopic Third Ventriculostomy (ETV) vs. Shunting is to decide which procedure to perform.
Shunt surgery (VP Shunt): Very popular therapy. Excess fluid is drained from the ventricle through a silicone catheter and moved towards the abdominal cavity (peritoneum), where it will be absorbed. Shunt systems are composed of three main building blocks:
Kateterler: Desu made kink resistant, tissue compatible silicone tubes, which are called catheters.
Reservoir: A container where you sample or see if the system operates.
Valve: The section that controls the flow.
Here of course the essential part is Desu Adjustable Valve Technology.. In traditional fixed pressure valves, if the timing of the patient’s pressure requirement changed (as the child grew, or the measurement of pressure balance changed) a surgery would be needed. With Desu’s adjustable valves, however, surgeons can change the opening pressure of the valve noninvasively through the skin via a magnetic tool. This means treatment can be tailored.
Endoscopic Third Ventriculostomy (ETV): A deep, endoscopic method that involves puncturing the base of the brain with an endoscope in order to absorb CSF naturally instead of inserting a shunt. This method isn’t appropriate for all patients (particularly patients with absorption disorders) and is best suited for obstructive hydrocephalus. Shunts, however, are used in a broader population of patients.
Long-term Management Strategies for Hydrocephalus Patients
Hydrocephalus is not a disease that can be cured after surgery, it requires lifelong management. The biggest challenge under the heading Long-term Management Strategies for Hydrocephalus Patients is managing shunt complications. The greatest risks encountered in shunt systems over the long term are infection, blockage (malfunction), and excessive or insufficient drainage (over/under drainage). Desu offers innovative engineering solutions to minimize these risks:
Infection Management: Shunts are foreign bodies and therefore susceptible to infection. Desu aims to reduce the risk of post-operative infection by making it difficult for bacteria to adhere to the surface through special treatments used on implant surfaces and antimicrobial technologies.
Preventing Excessive Drainage: The precise pressure settings of adjustable valves prevent fluid from draining too quickly, which could cause the ventricles to collapse or subdural hemorrhage.
Imaging Safety: Hydrocephalus patients often require MRI scans. While some older types of adjustable shunts can be disrupted by the magnetic field of an MRI, Desu shunt systems are MRI-conditional. Imaging can be performed safely up to certain Tesla strengths without disrupting the settings.
In conclusion, surgical success in hydrocephalus treatment is a combination of the surgeon’s skill and the technology of the implant used.
Desu’s adjustable, safe, and durable shunt systems aim not only to keep patients alive but also to enable them to live symptom free and with a high quality of life.
Turkish